Turtle Cameron
CIK 0001758363
Chief Executive OfficerDirector
Filings
15
Latest Jun 3, 2026
Issuers covered
3
Showing
15 of 15
Page 1
Track record
19 of 22 open-market trades scored (86% price coverage) - 3 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 19 | 0% | -15.2% | -14.3% | -0.5% | -42.0% |
| 90 days | 11 | 0% | -62.7% | -55.6% | -37.7% | -111.1% |
| 180 days | 4 | 0% | -167.0% | -167.0% | -143.4% | -190.7% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Turtle Cameron has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | 13 | Jun 3, 2026 |
| GLTO | Galecto, Inc. | 1 | Mar 25, 2026 |
| ORKA | Oruka Therapeutics, Inc. | 1 | Jun 3, 2025 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|